An Analysis Of CVS Health Corporation (CVS)’s Weekly Performance

As of Friday close, CVS Health Corporation’s (NYSE:CVS) stock was down -$0.77, moving down -0.78 percent to $97.48. The average number of shares traded per day over the past five days has been 5,291,600 shares. 1 time new highs have been achieved over the past 5 days, with a -$3.21 fall in that time frame. In the last twenty days, the average volume was 5,720,455, while in the previous 50 days, it was 5,681,126.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Since last month, CVS stock retreated -7.14%. Shares of the company fell to $95.02 on 05/02/22, the lowest level in the past month. A 52-week high of $111.25 was reached on 02/08/22 after having rallying from a 52-week low of $79.33. Since the beginning of this year, CVS’s stock price has dropped by -5.51% or -$5.68, and marked a new high 8 times. However, the stock has declined by -12.38% since its 52-week high.

CVS Health Corporation (CVS) last reported insider trading activity 36 days ago on Apr 08. Shah Prem S, the EVP and Co-President of Retail of the company, disposed of 16,954 shares for $105.00 on Apr 08. It resulted in a $1,780,170 divestment by the insider. Finke Daniel P sold 5,941 shares at an average price of $100.00 on Apr 05. The insider now owns 32,150 shares following the transaction. On Apr 04, EVP/Pres, Health Care Benefits Finke Daniel P sold 55,359 shares at $100.13 apiece. The transaction was valued at $5,543,097.

Valuation Metrics

Right now, CVS Health Corporation (CVS) has a P/E ratio of about 16.20. The stock’s beta is 0.77. Besides these, the trailing price-to-sales (P/S) ratio of 0.41, the price-to-book (PB) ratio of 1.73, and the price-to-cash flow ratio of 8.54 may also be considered.

The latest dividend of $0.55 per share was paid out, remained unchanged from last year’s $0.55. On Friday December 10 2021, a $0.05 dividend increase was announced.

Financial Health

In the three months ended September 29, CVS Health Corporation’s quick ratio stood at 0.60, while its current ratio was 0.90, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.71, and the total debt-to-equity ratio was 0.76. On the profitability front, the trailing twelve-month gross margin is 39.80% percent. In the year ended September 29, operating margins totaled 4.20%. Based on annual data, CVS earned $116.31 billion in gross profit and brought in $292.11 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 7.80%. Return on equity (ROE) for the past 12 months was 10.80%.

In CVS Health Corporation’s quarter-end financial report for September 29, it reported total debt of $52.06 billion against cash and short-term investments of $2.9 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CVS’s revenue rose 10.06% to $76.6 billion during the quarter, while net income inched up to $76.83 billion. While analysts expected CVS Health Corporation to report $1.78 quarterly earnings, the actual figure was $1.97 per share, beating the consensus estimate by 10.70%. During the quarter, the company generated $4.54 billion in EBITDA. The liabilities of CVS Health Corporation were 158.73 billion at the end of its most recent quarter ended September 29, and its total debt was $78.66 billion. The value of shareholders’ equity is $1.31 billion.

Technical Picture

This quick technical analysis looks at CVS Health Corporation’s (CVS) price momentum. With a historical volatility rate of 34.97%, the RSI 9-day stood at 40.81% on 13 May.

With respect to its five-day moving average, the current CVS Health Corporation price is down by -3.19% percent or -$3.21. At present, CVS shares trade -5.98% below its 20-day simple moving average and -2.83% percent below its 100-day simple moving average. However, the stock is currently trading approximately -6.75% below its SMA50 and +17.36% above its SMA200.

Stochastic coefficient K was 34.70% and Stochastic coefficient D was 32.75%, while ATR was 2.69. Given the Stochastic reading of 31.18% for the 14-day period, the RSI (14) reading has been calculated as 41.69%. As of today, the MACD Oscillator reading stands at -0.51, while the 14-day reading stands at -0.77.

Analyst Ratings

CVS Health Corporation downgraded its rating on CVS Health Corporation (NYSE: CVS) to a Hold in a note to investors on March 29, 2022. The analysts firm previously had a Buy rating on the stock.CVS Health Corporation (CVS) has been rated Overweight by analysts. According to 0 brokerage firms, CVS is a sell, and 7 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 4 analysts rate CVS Health Corporation stock as buy, with 12 recommending it as overweight.

With a median target price of $119.10, the current consensus forecast for the stock is $98.00 – $127.00. Based on these forecasts, analysts predict CVS Health Corporation (CVS) will achieve an average price target of $117.85.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles